España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Vericel
VCEL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$57.43
0.01000
0.02%
At close: -
$57.44
0.01000
0.02%
After Hours: Jan 24, 4:00 PM EDT
Get Report
Comment
Vericel (VCEL) Forecast
News
Earnings
Vericel (VCEL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Vericel (NASDAQ:VCEL) Stock
Vericel Stock (NASDAQ: VCEL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 15, 2025
Stephens & Co. Reiterates Overweight on Veric...
Benzinga Newsdesk
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Beyond The Numbers: 5 Analysts Discuss Vericel Stock
Benzinga Insights
Market-Moving News for January 15th
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Vericel...
Benzinga Newsdesk
Vericel shares are trading lower after the co...
Benzinga Newsdesk
Tuesday, January 14, 2025
Vericel shares are trading lower after the co...
Benzinga Newsdesk
Vericel Sees Prelim. 2024 Total Net Revenue $...
Benzinga Newsdesk
Wednesday, December 18, 2024
Truist Securities Maintains Buy on Vericel, R...
Benzinga Newsdesk
Tuesday, November 26, 2024
BTIG Maintains Buy on Vericel, Raises Price T...
Benzinga Newsdesk
Tuesday, November 19, 2024
Canaccord Genuity Maintains Buy on Vericel, M...
Benzinga Newsdesk
Friday, November 08, 2024
HC Wainwright & Co. Reiterates Buy on Vericel...
Benzinga Newsdesk
Thursday, November 07, 2024
Vericel Affirms FY24 Sales Guidance Of $238.0...
Benzinga Newsdesk
Vericel Q3 2024 GAAP EPS $(0.02) Beats $(0.05...
Benzinga Newsdesk
Wednesday, November 06, 2024
Earnings Preview For Vericel
Benzinga Insights
Tuesday, August 27, 2024
Vericel Corp shares are trading higher after ...
Benzinga Newsdesk
The Analyst Verdict: Vericel In The Eyes Of 7 Experts
Benzinga Insights
TD Cowen Maintains Buy on Vericel, Raises Pri...
Benzinga Newsdesk
Monday, August 26, 2024
Vericel Gains FDA Approval for Arthroscopic D...
Benzinga Newsdesk
Friday, August 16, 2024
Vericel Corp Files For Mixed Shelf Offering; ...
Benzinga Newsdesk
Thursday, August 15, 2024
Vericel Gets FDA Approval Of NexoBrid For The...
Benzinga Newsdesk
Friday, August 09, 2024
Expert Ratings For Vericel
Benzinga Insights
Canaccord Genuity Initiates Coverage On Veric...
Benzinga Newsdesk
Friday, August 02, 2024
Stephens & Co. Maintains Overweight on Verice...
Benzinga Newsdesk
The Latest Analyst Ratings For Vericel
Benzinga Insights
Apple To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Vericel,...
Benzinga Newsdesk
Thursday, August 01, 2024
Vericel shares are trading lower after the co...
Benzinga Newsdesk
Vericel Affirms FY24 Sales Guidance Of $238M-...
Benzinga Newsdesk
Vericel Q2 2024 GAAP EPS $(0.10) Misses $(0.0...
Benzinga Newsdesk
Tuesday, July 16, 2024
A Glimpse Into The Expert Outlook On Vericel Through 4 Analysts
Benzinga Insights
Truist Securities Maintains Buy on Vericel, R...
Benzinga Newsdesk
Monday, July 15, 2024
BTIG Maintains Buy on Vericel, Lowers Price T...
Benzinga Newsdesk
Thursday, June 20, 2024
Vericel shares are trading higher after TD Co...
Benzinga Newsdesk
TD Cowen Initiates Coverage On Vericel with B...
Benzinga Newsdesk
Thursday, May 09, 2024
Critical Insights From Vericel Analyst Ratings: What You Need To Know
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Vericel,...
Benzinga Newsdesk
Wednesday, May 08, 2024
Vericel Raises FY24 Revenue Guidance From $23...
Benzinga Newsdesk
Vericel Q1 EPS $(0.08) Beats $(0.11) Estimate...
Benzinga Newsdesk
Tuesday, March 26, 2024
Analyst Scoreboard: 5 Ratings For Vericel
Benzinga Insights
Truist Securities Reiterates Buy on Vericel, ...
Benzinga Newsdesk
Friday, March 01, 2024
A Closer Look at 4 Analyst Recommendations For Vericel
Benzinga Insights
Truist Securities Maintains Buy on Vericel, R...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Vericel,...
Benzinga Newsdesk
Thursday, February 29, 2024
Vericel Forecasts 2024 Revenue Of $237M-$241M...
Benzinga Newsdesk
Vericel Q4 GAAP EPS $0.26 Beats $0.17 Estimat...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Thursday, January 25, 2024
Truist Securities Upgrades Vericel to Buy, Ra...
Benzinga Newsdesk
Tuesday, January 16, 2024
HC Wainwright & Co. Maintains Buy Rating for Vericel: Here's What You Need To Know
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Vericel,...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch